May 21 |
INVO Bioscience files for $100M mixed shelf
|
May 16 |
INVO BioScience reports Q1 results
|
May 15 |
Peering Into INVO Bioscience's Recent Short Interest
|
May 15 |
INVO Reports Record First Quarter 2024 Financial Results
|
Apr 16 |
INVO BioScience reports Q4 results
|
Apr 16 |
INVO Reports Fourth Quarter and Full Year 2023 Financial Results
|
Jan 23 |
NAYA Biosciences to buy gene therapy company Florida Biotechnologies
|
Jan 23 |
NAYA Biosciences To Acquire Clinical Stage Gene Therapy ProgramĀ for Leber's Hereditary Optic Neuropathy (LHON)
|
Jan 17 |
INVO, NAYA announce new board members ahead of merger
|
Jan 17 |
INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors
|